6533b834fe1ef96bd129e335
RESEARCH PRODUCT
Successful “Salvage” Therapy of Intravenous Cyclophosphamide for Refractory Polymyositis in an Elderly Patient: Case Report
Domenico Di RaimondoAntonino TuttolomondoR. Di SciaccaGiuseppe LicataPaola FernandezAntonio PintoM. Di Gatisubject
Pharmacologymedicine.medical_specialtybusiness.industryImmunologySalvage therapyDermatomyositismedicine.diseasePolymyositisSurgery03 medical and health sciences0302 clinical medicineIntravenous cyclophosphamideRefractory030220 oncology & carcinogenesismedicineImmunology and AllergyElderly patientbusiness030215 immunologydescription
Dermatomyositis and polymyositis may affect children and adults and are now widely recognized as major causes of disability which, thanks to the introduction of immunosuppressive drugs, is often treatable, at least to some extent. Few data exist regarding polymyositis in elderly patients. We describe a case of refractory life-threatening polymyositis in an elderly patient, successfully treated with intravenous cyclophosphamide.
year | journal | country | edition | language |
---|---|---|---|---|
2006-10-01 | International Journal of Immunopathology and Pharmacology |